SCHEMBL20205659

SCHEMBL20205659

CC1(C)c2cc(-c3cc(-c4ccccc4)cc(-c4cccc(-c5ccccc5)c4)c3)ccc2-c2ccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5cc6c(c7c5oc5ccccc57)-c5cc7c(cc5C6(C)C)-c5c(cc(-c6ccc8c(c6)C(C)(C)c6cc(-c9ccc%10c(c9)C(C)(C)c9cc(-c%11cc(-c%12ccccc%12)cc(-c%12cccc(-c%13ccccc%13)c%12)c%11)ccc9-%10)ccc6-8)c6oc8ccccc8c56)C7(C)C)ccc3-4)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.36
▸ PLA2G4A P47712 3/20 0.36
▸ ALOX5 P09917 2/20 0.35
▸ CDC14B O60729 2/20 0.34
▸ CDC14A Q9UNH5 2/20 0.34
▸ PLA2G10 O15496 1/20 0.34
▸ MAPT P10636 4/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ PKM P14618 2/20 0.33
▸ RECQL P46063 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALPI P09923 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23351760 0.96 PLA2G2A (0.33) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205327 0.96 PLA2G2A (0.34) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205333 0.94 PLA2G2A (0.36) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL24649753 0.92 PLA2G2A (0.35) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205657 0.92 ALOX5 (0.34) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205405 0.92 PLA2G2A (0.32) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205379 0.91 CDC14B (0.35) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205323 0.90 PLA2G2A (0.34) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205371 0.90 ALOX5 (0.37) ALOX5CDC14BCDC14AMAPTKDM4E
SCHEMBL20205603 0.90 MAPT (0.32) MAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PLA2G2A 1854/4885PLA2G4A 2777/4885ALOX5 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback